COSIMA: COronary SInus Reducer for the Treatment of Refractory Microvascular Angina

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
Patients with refractory microvascular angina fulfilling the predefined inclusion and exclusion criteria will be enrolled in this randomized trial. The primary objective is to investigate whether the proportion of patients reporting an improvement in Canadian Cardiovascular Society (CCS) angina class (≥2 classes) is different at six months after implantation of a Coronary Sinus Reducer followed by optimal medical therapy (OMT) compared to OMT alone.
Epistemonikos ID: 919b398412221d83019b9b1b7b65eca4d355d516
First added on: May 07, 2024